Randomized study evaluating the impact of an innovative and cooperative pathway integrating OncoGeriatric, pharmaceutical and Pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy. (POG)
Sponsor: Institut Gustave Roussy
Phase:
Disease: Cancer
EU trial number: 2025-523610-83-00
Population: Patients older than 70 years with cancer who are treated with oral therapy.
Register Investigator Interest
Interested in offering this trial to suitable patients?